Attached files
file | filename |
---|---|
EX-23.1 - EX-23.1 - Sagent Pharmaceuticals, Inc. | d855921dex231.htm |
EX-31.1 - EX-31.1 - Sagent Pharmaceuticals, Inc. | d855921dex311.htm |
EX-23.3 - EX-23.3 - Sagent Pharmaceuticals, Inc. | d855921dex233.htm |
EX-23.2 - EX-23.2 - Sagent Pharmaceuticals, Inc. | d855921dex232.htm |
EX-31.2 - EX-31.2 - Sagent Pharmaceuticals, Inc. | d855921dex312.htm |
EX-32.1 - EX-32.1 - Sagent Pharmaceuticals, Inc. | d855921dex321.htm |
EXCEL - IDEA: XBRL DOCUMENT - Sagent Pharmaceuticals, Inc. | Financial_Report.xls |
10-K - 10-K - Sagent Pharmaceuticals, Inc. | d855921d10k.htm |
Exhibit 21.1
Company Name |
State of Incorporation/ Organization |
Country of Incorporation/ Organization | ||||||
Sagent Pharmaceuticals, Inc. |
Wyoming | United States of America | ||||||
Sagent International LLC |
Cayman Islands | |||||||
Sagent (China) Pharmaceuticals Co. Ltd. |
China | |||||||
Omega Laboratories Limited |
Canada | |||||||
7685947 Canada, Inc. |
Canada | |||||||
Sagent Acquisition Corp. |
Canada |